The FDA just approved Sage Therapeutics medication Zulresso™, the first drug approved for treating postpartum depression. Postpartum depression affects about one in nine women, but until now, quick and effective treatment has been elusive for many struggling moms. In trials, Zulresso™ reduced symptoms of postpartum depression within days. The manufacturer anticipates that the drug will be available to the public starting in June.
Sage Therapeutics ZULRESSO™
To learn more about ZULRESSO™, visit Sage Therapeutics’ website.